Bard hernia product recall labelled with most serious classification:
This article was originally published in Clinica
The US FDA has designated CR Bard's worldwide recall of its ventral hernia repair product, the Composix Kugel mesh X-large patch, as a class I recall. The company has initiated the action in December 2005 following reports that the device's "memory" coil ring, which holds the patch in place after insertion, broke after insertion into the abdomen. This could lead to bowel perforation and/or the creation of abnormal connections between the intestines and other organs. The company's fourth-quarter revenues took a $7.8m hit as a result of the recall (see Clinica No 1192, p 19).
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.